trastuzumab,neratinib
roche,puma,turning point therapeutics
['summit', 'breast', 'pbyi', '$tptx', 'puma']
breaking news: $pbyi puma biotechnology presents outcomes from the metastatic breast cancer cohort of the summit trial at the asco 2022 annual meeting #mwn #stocks $tptx $bq $efoi
Market Wire News is a news platform to help research, connect and engage